D. Mozaffarian, E. Benjamin, A. Go, D. Arnett, M. Blaha et al., Heart Disease and Stroke Statistics???2016 Update, Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association, pp.38-360, 2016.
DOI : 10.1161/CIR.0000000000000350
URL : http://circ.ahajournals.org/content/circulationaha/133/4/e38.full.pdf

A. Moss, W. Hall, D. Cannom, J. Daubert, S. Higgins et al., Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia, New England Journal of Medicine, vol.335, issue.26, pp.1933-1940, 1996.
DOI : 10.1056/NEJM199612263352601

A. Moss, W. Zareba, W. Hall, H. Klein, D. Wilber et al., Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction, New England Journal of Medicine, vol.346, issue.12, pp.877-883, 2002.
DOI : 10.1056/NEJMoa013474

G. Bardy, K. Lee, D. Mark, J. Poole, D. Packer et al., Amiodarone or an Implantable Cardioverter???Defibrillator for Congestive Heart Failure, New England Journal of Medicine, vol.352, issue.3, pp.225-237, 2005.
DOI : 10.1056/NEJMoa043399

S. Hohnloser, K. Kuck, P. Dorian, R. Roberts, J. Hampton et al., Prophylactic Use of an Implantable Cardioverter???Defibrillator after Acute Myocardial Infarction, New England Journal of Medicine, vol.351, issue.24, pp.2481-2488, 2004.
DOI : 10.1056/NEJMoa041489

V. Kutyifa, A. Moss, H. Klein, Y. Biton, S. Mcnitt et al., Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac PatientsCLINICAL PERSPECTIVE, Circulation, vol.132, issue.17, pp.1613-1619, 2015.
DOI : 10.1161/CIRCULATIONAHA.115.015677

T. Tanawuttiwat, J. Garisto, A. Salow, J. Glad, S. Szymkiewicz et al., Protection from Outpatient Sudden Cardiac Death following ICD Removal Using a Wearable Cardioverter Defibrillator, Pacing and Clinical Electrophysiology, vol.43, issue.5, pp.562-568, 2014.
DOI : 10.1016/j.jelectrocard.2009.05.010

A. Feldman, H. Klein, P. Tchou, S. Murali, W. Hall et al., Use of a Wearable Defibrillator in Terminating Tachyarrhythmias in Patients at High Risk for Sudden Death:. Results of WEARIT/BIROAD, Pacing and Clinical Electrophysiology, vol.25, issue.1, pp.4-9, 2004.
DOI : 10.1046/j.1460-9592.2002.00004.x

M. Chung, S. Szymkiewicz, M. Shao, E. Zishiri, M. Niebauer et al., AGGREGATE NATIONAL EXPERIENCE WITH THE WEARABLE CARDIOVERTER-DEFIBRILLATOR VEST: EVENT RATES, COMPLIANCE AND SURVIVAL, Journal of the American College of Cardiology, vol.55, issue.10, pp.194-203, 2010.
DOI : 10.1016/S0735-1097(10)60099-X

A. Epstein, W. Abraham, N. Bianco, K. Kern, M. Mirro et al., Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction, Journal of the American College of Cardiology, vol.62, issue.21, 2000.
DOI : 10.1016/j.jacc.2013.05.086

H. Klein, U. Meltendorf, S. Reek, J. Smid, S. Kuss et al., Bridging a temporary high risk of sudden arrhythmic death

A. Auricchio, H. Klein, C. Geller, S. Reek, M. Heilman et al., Clinical Efficacy of the Wearable Cardioverter-Defibrillator in Acutely Terminating Episodes of Ventricular Fibrillation, The American Journal of Cardiology, vol.81, issue.10, pp.1253-1256, 1998.
DOI : 10.1016/S0002-9149(98)00120-9

M. Lamichhane, J. Gardiner, N. Bianco, S. Szymkiewicz, and R. Thakur, National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy, Journal of Interventional Cardiac Electrophysiology, vol.27, issue.1, pp.11-19, 2017.
DOI : 10.1016/S0735-1097(03)00789-7

N. Wäßnig, M. Günther, S. Quick, C. Pfluecke, F. Rottstädt et al., Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac DeathClinical Perspective, Circulation, vol.134, issue.9, pp.635-643, 2016.
DOI : 10.1161/CIRCULATIONAHA.115.019124

N. Salehi, M. Nasiri, N. Bianco, M. Opreanu, V. Singh et al., The Wearable Cardioverter Defibrillator in Nonischemic Cardiomyopathy: A US National Database Analysis, Canadian Journal of Cardiology, vol.32, issue.10, 2016.
DOI : 10.1016/j.cjca.2015.12.035

S. Priori, C. Blomström-lundqvist, A. Mazzanti, N. Blom, M. Borggrefe et al., 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, European Heart Journal, vol.18, issue.(Suppl 1), pp.1601-1687, 1093.
DOI : 10.1016/j.hrthm.2010.04.033

J. Piccini, L. Allen, P. Kudenchuk, R. Page, M. Patel et al., Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death, Circulation, vol.133, issue.17, pp.1715-1727, 2016.
DOI : 10.1161/CIR.0000000000000394

S. Solomon, S. Zelenkofske, J. Mcmurray, P. Finn, E. Velazquez et al., Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both, New England Journal of Medicine, vol.352, issue.25, pp.2581-2588, 2005.
DOI : 10.1056/NEJMoa043938

D. Exner, K. Kavanagh, M. Slawnych, L. Mitchell, D. Ramadan et al., Noninvasive Risk Assessment Early After a Myocardial Infarction, Journal of the American College of Cardiology, vol.50, issue.24, pp.2275-2284, 2007.
DOI : 10.1016/j.jacc.2007.08.042

D. Wilber, W. Zareba, W. Hall, M. Brown, A. Lin et al., Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction, Circulation, vol.109, issue.9, pp.1082-1084, 2004.
DOI : 10.1161/01.CIR.0000121328.12536.07

G. Steinbeck, D. Andresen, K. Seidl, J. Brachmann, E. Hoffmann et al., Defibrillator Implantation Early after Myocardial Infarction, New England Journal of Medicine, vol.361, issue.15, pp.1427-1436, 2009.
DOI : 10.1056/NEJMoa0901889

J. Olgin, M. Vaughan-sarrazin, E. Hannan, C. Gormley, and G. Rosenthal, Vest Prevention of Early Sudden Death Trial and VEST Registry. [accessed 2015 Feb 18] Available from: URL: https:// clinicaltrials.gov/ct2/show Mortality in Medicare beneficiaries following coronary artery bypass graft surgery in states with and without certificate of need regulation, JAMA, vol.288, pp.1859-1866, 2002.

E. Zishiri, S. Williams, E. Cronin, E. Blackstone, S. Ellis et al., Early Risk of Mortality After Coronary Artery Revascularization in Patients With Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator, Circulation: Arrhythmia and Electrophysiology, vol.6, issue.1, pp.117-128, 2013.
DOI : 10.1161/CIRCEP.112.973552

H. Fieguth, T. Wahlers, H. Trappe, and H. Borst, Arrhythmogenic mortality in heart-transplant candidates, Transplant International, vol.16, issue.11, pp.219-220, 1996.
DOI : 10.1111/j.1540-8159.1993.tb01558.x

S. Pettit, M. Petrie, D. Connelly, A. Japp, J. Payne et al., Use of implantable cardioverter defibrillators in patients with left ventricular assist devices, European Journal of Heart Failure, vol.30, issue.7, pp.696-702, 2012.
DOI : 10.1093/eurheartj/ehp247

M. Opreanu, C. Wan, V. Singh, N. Salehi, J. Ahmad et al., Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis, The Journal of Heart and Lung Transplantation, vol.34, issue.10, pp.1305-1309, 2015.
DOI : 10.1016/j.healun.2015.04.004

A. Kadish, A. Dyer, J. Daubert, R. Quigg, N. Estes et al., Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy, New England Journal of Medicine, vol.350, issue.21, pp.2151-2158, 2004.
DOI : 10.1056/NEJMoa033088

M. Iacoviello and F. Monitillo, Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures, World Journal of Cardiology, vol.6, issue.7, pp.562-576, 2014.
DOI : 10.4330/wjc.v6.i7.562

J. Cohn and G. Tognoni, A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure, New England Journal of Medicine, vol.345, issue.23, pp.1667-1675, 2001.
DOI : 10.1056/NEJMoa010713

D. Bänsch, M. Antz, S. Boczor, M. Volkmer, J. Tebbenjohanns et al., Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT), Circulation, vol.105, issue.12, pp.1453-1458, 2002.
DOI : 10.1161/01.CIR.0000012350.99718.AD

F. Marchlinski and M. Jessup, Timing the Implantation of Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy??????Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology., Journal of the American College of Cardiology, vol.47, issue.12, pp.2483-2485, 2006.
DOI : 10.1016/j.jacc.2006.01.075

A. Kadish, A. Schaechter, H. Subacius, E. Thattassery, W. Sanders et al., Patients With Recently Diagnosed Nonischemic Cardiomyopathy Benefit From Implantable Cardioverter-Defibrillators, Journal of the American College of Cardiology, vol.47, issue.12, pp.2477-2482, 1056.
DOI : 10.1016/j.jacc.2005.11.090

L. Køber, J. Thune, J. Nielsen, J. Haarbo, L. Videbaek et al., Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure, New England Journal of Medicine, vol.375, issue.13, pp.1221-1230, 1056.
DOI : 10.1056/NEJMoa1608029

M. Singh, N. Wang, S. Jain, A. Voigt, S. Saba et al., Utility of the Wearable Cardioverter-Defibrillator in Patients With??Newly Diagnosed Cardiomyopathy, Journal of the American College of Cardiology, vol.66, issue.23, pp.2607-2613, 2015.
DOI : 10.1016/j.jacc.2015.09.079

6. Wjc|www, . Wjgnet, C. Eitel, S. Denef, S. Desch et al., com devices necessary? Prevalence and Clinical Significance of Life-Threatening Arrhythmias in Takotsubo Cardiomyopathy, Heart Rhythm J Am Coll Cardiol, vol.13, issue.65, pp.1979-1986, 2015.

F. Nascimento, R. Krishna, H. Hrachian, and O. Santana, Wearable cardioverter defibrillator in stress cardiomyopathy and cardiac arrest, Case Reports, vol.2013, issue.sep13 1, pp.2013009789-24038288, 2013.
DOI : 10.1136/bcr-2013-009789

S. Peters and H. Klein, WCD LifeVest, Herz, vol.163, issue.2, pp.219-221, 2012.
DOI : 10.1176/appi.ajp.163.2.325

U. Elkayam, Clinical Characteristics of Peripartum Cardiomyopathy in the United States, Journal of the American College of Cardiology, vol.58, issue.7, pp.659-670, 2011.
DOI : 10.1016/j.jacc.2011.03.047

M. Honigberg and M. Givertz, Arrhythmias in Peripartum Cardiomyopathy, Cardiac Electrophysiology Clinics, vol.7, issue.2, pp.309-317, 2015.
DOI : 10.1016/j.ccep.2015.03.010

S. Whitehead, C. Berg, and J. Chang, Pregnancy-Related Mortality Due to Cardiomyopathy, Obstetrics & Gynecology, vol.102, issue.6, pp.1326-1331, 1991.
DOI : 10.1097/00006250-200312000-00019

D. Duncker, A. Haghikia, T. König, S. Hohmann, K. Gutleben et al., Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator, European Journal of Heart Failure, vol.108, issue.12, pp.1331-1336, 2014.
DOI : 10.1007/s00395-013-0366-9

C. Kawai, From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death : Learning From the Past for the Future, Circulation, vol.99, issue.8, pp.1091-1100, 1999.
DOI : 10.1161/01.CIR.99.8.1091

I. 46-kindermann, M. Kindermann, R. Kandolf, K. Klingel, B. Bültmann et al., Predictors of outcome in patients with suspected myocarditis Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study (ASAP) [accessed 2015 Feb 18] Available from: URL: https://clinicaltrials.gov/ct2/showUnited States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & amp; end-stage renal disease in the United States, Circulation Am J Kidney Dis Ann Noninvasive Electrocardiol, vol.118, issue.19, pp.639-648, 2008.

C. Herzog, S. Li, E. Weinhandl, J. Strief, A. Collins et al., Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators, Kidney International, vol.68, issue.2, pp.818-825, 2005.
DOI : 10.1016/S0085-2538(15)50904-6

M. Lapage, C. Canter, E. Rhee, C. Schuger, C. Beck et al., A Fatal Device-Device Interaction between a Wearable Automated Defibrillator and a Unipolar Ventricular Pacemaker, Pacing and Clinical Electrophysiology, vol.27, issue.7, pp.912-915, 1056.
DOI : 10.1111/j.1540-8159.2008.01110.x

C. Healy and R. Carrillo, Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation, Heart Rhythm, vol.12, issue.7, pp.1565-1573, 2015.
DOI : 10.1016/j.hrthm.2015.03.061

J. Barraud, Wearable cardioverter defibrillator review © 2017 Baishideng Publishing Group Inc. All rights reserved